ArticleBlood2024

Targeting the TNF/IAP pathway synergizes with anti-CD3 immunotherapy in T-cell acute lymphoblastic leukemia.

Andrea Ávila Ávila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.